Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New cytotoxic agents described for colon cancer therapy

Nov. 8, 2010

Bristol-Myers Squibb and Simcere to jointly develop BMS-817378

Nov. 8, 2010

Oncothyreon begins phase I/II trial of PX-866/docetaxel combination

Nov. 5, 2010

Adventrx Pharma submits NDA to FDA for vinorelbine

Nov. 5, 2010

Takeda and Millennium initiate phase III TAK-700 program in prostate cancer

Nov. 5, 2010

New progesterone receptor antagonists presented by Evestra

Nov. 5, 2010

Interim phase I/II data presented on dovitinib in RCC

Nov. 5, 2010

Preliminary phase II/III data disclosed on fosbretabulin plus chemotherapy in ATC

Nov. 5, 2010

MLN-8237 shows promise in epithelial ovarian, fallopian tube and primary peritoneal carcinoma

Nov. 5, 2010

Gynecologic Oncology Group to begin phase II elesclomol trial in ovarian cancer

Nov. 4, 2010

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...